Posted inComunicati
Innovative Molecules Announces Completion of Phase 1 Program and Advancement to Phase 2 for Oral Adibelivir
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE MUNICH, Jan. 29, 2026 /PRNewswire/ -- Innovative Molecules GmbH, a…
diretta News